GLIKLAZID ACTAVIS

30MG TBL MRL 120 II

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 25.01.2021
Interruption of marketing 20.11.2020 0112659, 0001290, 0018390, 0234451, 0234454, 0241849
Capacity/distribution reasons 15.01.2021
Resumption of marketing 16.07.2020
Interruption of marketing 06.01.2020 0112659, 0112666, 0001290, 0018390, 0234451
Capacity/distribution reasons 4/2020
Resumption of marketing 01.09.2017
Interruption of marketing 01.07.2017 0112659, 0112666, 0001290, 0147113, 0147116, 0018390, 0206431, 0206432
Resumption of marketing 07.04.2017
Interruption of marketing 15.03.2017 0112659, 0112666, 0001290, 0147116, 0018390, 0206431, 0206432
Placing on the market 16.10.2015

All reports are available in the Overview.

Back to list